Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes - Watanabe - 2020 - Journal of Diabetes Investigation - Wiley Online Library
Glycaemic control and hypoglycaemia in metformin-treated T2DM patients with exenatide BID vs insulin lispro TID added to titrated insulin glargine QD: the 4B trial - Media Centre | EASD
Exenatide - wikidoc
MTF Formulary Management for the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs)
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes | Cardiovascular Diabetology | Full Text
Bydureon® (exenatide once weekly) clinical data slide deck - ppt download
Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes - Wysham - 2018 - Diabetes, Obesity and Metabolism - Wiley Online Library
Comparison between twice-daily (BID) exenatide (10 mg) and once-daily... | Download Scientific Diagram
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - ScienceDirect
Mean direct medical cost (€) per patient receiving exenatide bid or... | Download Table
ADA: Efficacy and Safety of Lixisenatide Once-Daily vs. Exenatide Twice-Daily in Type 2 DM Inadequately Controlled on Metformin (GetGoal-X)
Overview of clinical trials comparing liraglutide qd with exenatide... | Download Table
Table 2 from Exenatide ( Byetta ) , an Incretin Mimetic : The First in a New Therapeutic Class in the Treatment of Diabetes | Semantic Scholar
Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metform
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice
Liraglutide Achieves A1C Targets More often than Sitagliptin or Exenatide when Added to Metformin in Patients with Type 2 Diabetes and a Baseline A1C <8.0% - Endocrine Practice
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial | Nature Communications
Abstract 13242: Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated With Exenatide BID or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLinkTM Database | Circulation
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - ScienceDirect
Liraglutide Versus Exenatide Once Weekly_ Persistence, Adherence, and Early Discontinuation
A1C Data | BYDUREON BCise® (exenatide extended-release) injectable suspension 2 mg | For HCPs
Product Information for Exenatide
Simulated progression of HbA1c in exenatide BID þ OAD (treatment arm)... | Download Scientific Diagram
Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial | Scientific Reports
